Franklin Covey CO
Market Movers (8-K)
NYSE
Franklin Covey announced third quarter fiscal 2026 financial results, with consolidated revenue increasing 1% to $67.8 million, driven by growth in its Enterprise North America division.
NYSE
Franklin Covey announced its third quarter 2026 financial results conference call will be held on July 1, 2026, with results expected after market close.
NYSE
Franklin Covey Co. reports second quarter fiscal 2026 financial results, highlighting a 99% increase in Adjusted EBITDA and reaffirming annual guidance.
NYSE
Franklin Covey Co. announced the scheduling of its second quarter 2026 financial results release and conference call for April 1, 2026.
NYSE
Franklin Covey Co. announced the results of its Annual Meeting of Shareholders held on January 23, 2026, where all director nominees were elected, executive compensation was approved, and Deloitte & Touche, LLP was ratified as the independent auditor.
NYSE
Franklin Covey Co. reported a consolidated revenue of $64.0 million for Q1 FY2026, a decrease from the prior year, but affirmed its annual guidance for fiscal 2026.
Quarterly Earnings (10-Q)
NYSE
Franklin Covey Co. reported a net income of $3.1 million for the third quarter of fiscal 2026, a significant improvement from a net loss in the prior year, driven by revenue growth and cost management.
NYSE
Franklin Covey Co. reported flat revenue for the second quarter of fiscal 2026, with a net loss of $2.0 million, but saw a significant increase in Adjusted EBITDA.
NYSE
Franklin Covey Co. reported a net loss of $3.3 million for the first quarter of fiscal 2026, driven by decreased revenue and increased restructuring costs, despite positive momentum in North America invoiced amounts.
Worse than expected
NYSE
Franklin Covey Co. reported a net loss of $1.4 million for the third quarter of fiscal 2025, a significant decline from the prior year's profit, primarily due to decreased revenue across its Enterprise and Education divisions and increased restructuring expenses.
Worse than expected
Delay expected
NYSE
Franklin Covey's Q2 results show a net loss despite growth in the Education Division, impacted by restructuring costs, macroeconomic conditions, and decreased revenue in certain segments.
Worse than expected
NYSE
Franklin Covey's first quarter results show a slight revenue increase but a significant drop in net income due to increased operating expenses and restructuring costs.
Worse than expected
Annual Reports (10-K)
NYSE
Franklin Covey Co. reported a significant drop in net income for fiscal year 2025 amidst macroeconomic challenges, despite strategic investments and subscription renewals.
Delay expected
Worse than expected
NYSE
Franklin Covey Co. achieved record revenue and improved profitability in fiscal year 2024, driven by growth in subscription services and strategic investments.
Better than expected
Insider Trading (Form 4)
NYSE
Colleen D Dom, COO of Franklin Covey Co, reported a transaction in 1,999 shares of common stock on July 13, 2026.
NYSE
Holly Procter, President of Enterprise Division at Franklin Covey, reported transactions involving company common shares.
NYSE
Robert A. Whitman, a Director at Franklin Covey Co., reported the acquisition of 26,258 common shares.
NYSE
Franklin Covey Director Robert A. Whitman reported gifting 4,834 common shares, maintaining a direct beneficial ownership of 707,977 shares.
NYSE
Franklin Covey Director Nancy Phillips acquired 5,778 common shares, increasing her beneficial ownership to 20,951 shares.
NYSE
Franklin Covey Co. Director Efrain Rivera acquired 5,778 common shares, increasing his direct beneficial ownership to 12,087 shares.
Proxy Statements (Def-14A)
NYSE
Franklin Covey Co. announces its Annual Meeting of Shareholders for January 23, 2026, following a challenging fiscal year 2025 marked by missed financial targets and strategic transitions.
Delay expected
Worse than expected
NYSE
Franklin Covey has amended its proxy statement to include historical information regarding securities authorized for issuance under its equity compensation plans as of August 31, 2024.
NYSE
DEFR14A: Franklin Covey Co. Clarifies Treatment of Abstentions in Amendment to 2022 Omnibus Incentive Plan
Franklin Covey Co. amends its proxy statement to clarify the treatment of abstentions and broker non-votes regarding the approval of the amendment to the company's 2022 Omnibus Incentive Plan.
NYSE
Franklin Covey Co. has announced its annual shareholder meeting for January 24, 2025, featuring proposals for director elections, executive compensation advisory vote, auditor ratification, and an amendment to the company's incentive plan.
Schedule 13G - Passive Investments
NYSE
Royce & Associates LP has filed an amended Schedule 13G, reporting beneficial ownership of 7.82% of Franklin Covey Co. common stock as of June 30, 2026.
NYSE
Askeladden Capital Management LLC and Samir Patel have reported a 5.3% beneficial ownership stake in Franklin Covey Co., as of March 23, 2026.
NYSE
Royce & Associates LP has reported a significant beneficial ownership stake of 9.03% in Franklin Covey Co., holding 1,042,625 shares.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Franklin Covey Co. following an internal realignment.
NYSE
SCHEDULE 13G/A: Royce & Associates LP Discloses 3.74% Stake in Franklin Covey
Royce & Associates LP has filed an amended Schedule 13G, reporting a 3.74% beneficial ownership stake in Franklin Covey Co. common stock.
NYSE
AllianceBernstein L.P. has reported beneficial ownership of 8.3% of Franklin Covey Co.'s common stock, held for investment purposes.